Venture Capital

Updated:

Emily's Entourage

Emily’s Entourage is a venture philanthropy-focused nonprofit organization headquartered in Merion Station, United States. It raises money and awareness to...

Emily's Entourage

Emily’s Entourage is a venture philanthropy-focused nonprofit organization headquartered in Merion Station, United States. It raises money and awareness to fund research, grants, venture philanthropy investments, and clinical trial initiatives. Its work is dedicated to finding treatments and a cure for rare mutations of cystic fibrosis affecting the final 10% of patients. The organization directs capital toward scientific research and clinical advancement within this specialized therapeutic area. Its investment approach blends grant-making with venture philanthropy to accelerate development of therapeutics for underserved cystic fibrosis populations. The firm’s strategy centers on catalytic funding aimed at closing gaps in rare disease research and drug development. Specific fund sizes, portfolio companies, and assets under management are not disclosed in the available information.

General information

Firm type

Venture Capital

Location

Country

United States

City

Merion Station

Corporate office

Merion Station, United States

Sector focus

Venture CapitalUnited States

Frequently asked questions

What is Emily’s Entourage?

Emily’s Entourage is a nonprofit organization that raises money and awareness to fund research, grants, venture philanthropy investments, and clinical trial initiatives aimed at finding treatments and a cure for rare mutations of cystic fibrosis affecting the final 10% of patients.

Where is Emily’s Entourage headquartered?

Emily’s Entourage is headquartered in Merion Station, United States.

What is Emily’s Entourage’s investment strategy?

It combines grants, venture philanthropy investments, and clinical trial funding to accelerate research and therapeutic development for rare cystic fibrosis mutations affecting the final 10% of patients.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Merion Station Venture Capital profiles